Quote:

---

If the next two patients confirm the results of the first two, the star is born.

---

It could not have been stated any better.

Lets' cross our fingers and keep our feet on the ground. A confirmation will be worth a lot for patients all over the world and, for us, investors. What we need is significant reductions in CTCs (patients #2 & #3) and stable data for the first patient.

These will be the most important results in CYDY's existence after the initial results for first patient taking into account the severity of the condition and the commercial potential imo.

I believe after 14 weeks we have already demonstrated we have a commercial drug for Oncology. Now the question is: how good it is, or, put it in another way: how long is he survival progression likely going to be ???

Waiting anxiously next few weeks ...